Bioanalytical Method Validation & Troubleshooting Assistant
Validate bioanalytical methods and troubleshoot assay failures with FDA-aligned guidance
What You Can Do
You can design and execute bioanalytical method validations aligned with FDA Guidance for Industry and ICH guidelines, interpret complex validation data against regulatory acceptance criteria, and systematically troubleshoot analytical failures to identify root causes and corrective actions. This skill accelerates validation timelines by 20–30%, minimizes regulatory rework, and provides structured decision trees for problems that typically require expert consultation.
Features
Build fit-for-purpose protocols for accuracy, precision, selectivity, matrix effects, and stability studies tailored to your analyte's properties
Compare your results against FDA and ICH thresholds for intra/inter-assay CV, accuracy bias, and stability acceptance ranges
Diagnose root causes of method failures (sample prep, calibration, instrument drift, selectivity) and recommend targeted corrective actions
Determine whether your study requires full validation, partial validation, or cross-validation based on method changes and regulatory guidance
Ensure your validation documentation and data interpretation align with FDA and ICH Q2(R2) expectations
Evaluate ion suppression/enhancement, cross-talk, and interference patterns in LC-MS/MS and immunoassay workflows
Assess bench-top, autosampler, freeze-thaw, and long-term stability results against ICH stability acceptance criteria
Example Output
Example 1: Protocol Design for a New LC-MS/MS Biomarker Assay
✓ Validation scope: Full validation (new analyte, new method) ✓ Accuracy: 85–115% recovery across 3 QC levels ✓ Precision: ≤15% CV (intra-assay), ≤20% CV (inter-assay) ✓ Selectivity: <20% interference at retention time in 6 individual lots ✓ Matrix effects: Ion suppression <25% with post-column infusion ✓ Stability: 24h bench-top, 72h autosampler, 5 freeze-thaw cycles, 90 days long-term (−20°C) ✓ Sample size recommendations: 6 replicates per QC level, 3 analytical runs
Example 2: Troubleshooting Poor Precision (CV >20%)
Diagnosis pathway:
- Root cause: Inconsistent sample prep recovery → pH drift in extraction buffer
- Corrective action: Implement pH monitoring during QC preparation; tighten buffer tolerance to ±0.1 units
- Re-validation scope: Partial (sample prep modification) — repeat precision runs + stability confirmation
- Expected outcome: CV reduction to 12–15% range
Example 3: Matrix Effects Assessment Interpretation
✓ Ion suppression: −18% (acceptable, <25% threshold) ✓ Post-column recovery comparison: 94% vs. solution standard (acceptable, 85–115%) ✓ Selectivity in 6 lot blanks: 0 interference events ✓ Recommendation: Proceed to bioanalytical study; consider matrix-matched calibration for regulatory confidence
What's Included
- SKILL.md: Complete instruction file with workflows, decision trees, and structured prompts
- Validation Protocol Template: Editable protocol outline for accuracy, precision, selectivity, matrix effects, and stability study design
- Acceptance Criteria Reference Table: FDA and ICH guidance thresholds for CV, accuracy, bias, matrix effects, and analyte-specific recommendations
- Troubleshooting Decision Tree & Root Cause Framework: Systematic diagnostic flowchart for common analytical failures with corrective action recommendations
- Validation Data Interpretation Checklist: Point-by-point guide for evaluating results against regulatory expectations and identifying gaps before submission
Who It's For
- Bioanalytical Scientists — Developing, validating, and troubleshooting LC-MS/MS and immunoassay methods
- Analytical Chemists — Designing method protocols and managing validation studies for drug development programs
- QA/QC Specialists — Reviewing validation data, interpreting acceptance criteria, and documenting regulatory compliance
- Biomarker Assay Developers — Establishing validated assays for clinical diagnostics and biomarker research
- Regulatory Affairs Professionals — Supporting method validation sections in INDs, NDAs, and clinical study reports
Best For
- Method validation protocol design and approval — Building ICH/FDA-aligned validation studies before lab work begins
- Validation data interpretation and reporting — Evaluating results against acceptance criteria and documenting regulatory compliance
- Troubleshooting analytical failures — Systematically diagnosing root causes and recommending targeted corrective actions
- Cross-validation and partial validation decisions — Determining scope of re-validation needed for method modifications
- Regulatory documentation and submissions — Supporting IND, NDA, and bioanalytical study report sections with structured compliance checks
You might also like
This skill organizes complex toxicology datasets, clinical adverse events, and mechanistic findings into structured, FDA/EMA-compliant safety narratives. You input raw safety data—adverse event summaries, laboratory results, animal study findings, vital signs—and receive draft safety summaries, detailed safety assessments, and expedited safety reports ready for regulatory submission. It handles IND applications, annual safety updates, clinical development safety overviews, and urgent safety communications with proper MedDRA coding and regulatory formatting.
by kody-w
You can submit tool designs—drawings, specifications, or descriptions—and Claude will evaluate manufacturability constraints, identify potential failure modes using structured frameworks, and recommend cost-reduction opportunities. You'll receive a prioritized report covering structural analysis, production feasibility, material efficiency, and design trade-offs.
by kody-w
You can take unstructured monitoring visit observations and convert them into formal, audit-ready reports that categorize findings by risk level (Critical, Major, Minor), validate protocol compliance, and generate actionable follow-up items with assigned owners and resolution dates. The skill ensures your documentation meets FDA inspection standards and ICH-GCP requirements while creating clear escalation pathways for high-risk issues.
by kody-w
You can automate the validation of clinical trial data against protocol specifications, identify discrepancies including missing values, out-of-range results, protocol violations, and CRF inconsistencies. The skill generates audit-ready query documentation, categorizes anomalies by severity and type, resolves root causes systematically, and produces FDA inspection-ready reports that trace every data decision and corrective action for CDISC and regulatory submission.
by kody-w
You can submit raw mass spectrometry observations, instrument parameters, or sample preparation details to Claude and receive targeted diagnostic frameworks that explain anomalous results. Claude systematically generates plausible mechanistic explanations for unexpected protein abundance patterns, quantification inconsistencies, and PTM findings—then helps you design minimal, hypothesis-driven troubleshooting experiments to test them.
by kody-wThis skill interprets your FEA simulation results and extracts actionable design improvements. You can pinpoint stress concentrations, validate designs against safety factors and material limits, and receive specific geometry recommendations to reduce weight or improve performance. By automating FEA post-processing, you compress design iteration cycles and make engineering decisions faster.
by kody-w
You can validate eCRF and paper CRF datasets against protocol-defined rules, automatically identify data discrepancies (missing fields, out-of-range values, date inconsistencies), generate structured Data Query Forms (DQFs) for site clarification, track resolution status, and create audit-ready compliance documentation that meets FDA 21 CFR Part 11 and GCP requirements. This workflow reduces manual validation time while ensuring 100% traceability and regulatory readiness for inspections.
by kody-w
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w